Loading clinical trials...
Loading clinical trials...
Phase I Clinical Study on the Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors
Conditions
Interventions
Utidelone Capsule
Locations
1
United States
University of Southern California
Los Angeles, California, United States
Start Date
June 9, 2023
Primary Completion Date
April 15, 2024
Completion Date
December 31, 2024
Last Updated
November 9, 2023
NCT05720117
NCT06898450
NCT05719558
NCT05098132
NCT07477743
NCT07029399
Lead Sponsor
Biostar Pharma, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions